Grants per year
- 1 - 25 out of 38 results
Search results
-
Active
CBC_NU DF-021 PI-Daniel Batlle: Novel Form of Short ACE2 for Treatment of Scleroderma Kidney in a Mouse Model for the amount of $36,980 for period 4/1/2023 - 9/30/2023
Batlle, D. (Other) & Batlle, D. (Other)
Searle Funds at The Chicago Community Trust
1/1/17 → 12/31/25
Project: Research project
-
Finished
Lung delivery of novel ACE2 proteins for COVID-19
Batlle, D. (PD/PI) & Wysocki, J. (Co-Investigator)
Angiotensin Therapeutics, Inc., National Heart, Lung, and Blood Institute
9/1/22 → 2/29/24
Project: Research project
-
Novel Short ACE2 variant for Delayed Graft Function
Batlle, D. (PD/PI), Ansari, M. J. I. (Co-Investigator), Wysocki, J. (Co-Investigator) & Zhang, Z. J. (Co-Investigator)
National Institute of Allergy and Infectious Diseases
11/1/21 → 10/31/24
Project: Research project
-
NCR-19-2039- Ammonium excretion in ZS-9 treated mice with CKD
Batlle, D. (PD/PI) & Wysocki, J. (Co-Investigator)
AstraZeneca Pharmaceuticals LP
5/26/20 → 10/31/22
Project: Research project
-
The Role of MicroRNAs in Corneal Epithelial Homeostasis
Lavker, R. M. (PD/PI), Batlle, D. (Co-PD/PI), Peng, H. (Co-PD/PI) & Thaxton, C. S. (Co-PD/PI)
7/1/19 → 7/31/24
Project: Research project
-
PERL: A multicenter clinical trial of allopurinol to prevent GFR loss in T1D
Molitch, M. E. (PD/PI), Batlle, D. (Co-Investigator) & Wallia, A. (Co-Investigator)
Joslin Diabetes Center, Inc., National Institute of Diabetes and Digestive and Kidney Diseases
9/15/17 → 6/30/19
Project: Research project
-
Prot #16244: A Randomized, Double-blind, Placebo-Controlled, Parallel-Group, Multicenter, Event-Driven Phase III Study to Investigate the Efficacy and Safety of Finerenone, in Addition to Standard of Care, on the Progression of Kidney Disease in Subjects
Huang, W. (PD/PI), Batlle, D. (Co-Investigator), Wallia, A. (Co-Investigator) & Molitch, M. E. (Other)
Bayer HealthCare Pharmaceuticals, Inc.
1/5/16 → 5/31/20
Project: Research project
-
Urinary Renin Angiotensin System in Diabetes
Batlle, D. (PD/PI), Molitch, M. E. (Co-Investigator), Rademaker, A. W. (Co-Investigator) & Wysocki, J. (Co-Investigator)
National Institute of Diabetes and Digestive and Kidney Diseases
6/15/15 → 4/30/20
Project: Research project
-
Prot #BAY 94-8862/16243: A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Safety and Efficacy of Different Oral Doses of BAY-94-8862 in Subjects with Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Nephropa
Molitch, M. E. (PD/PI), Batlle, D. (Co-PD/PI) & Wallia, A. (Co-PD/PI)
Bayer HealthCare Pharmaceuticals, Inc.
1/2/14 → 1/2/17
Project: Research project
-
PERL: A multicenter clinical trial of allopurinol to prevent GFR loss in T1D
Molitch, M. E. (PD/PI), Batlle, D. (Co-Investigator) & Wallia, A. (Co-Investigator)
Joslin Diabetes Center, Inc., National Institute of Diabetes and Digestive and Kidney Diseases
9/30/13 → 8/31/17
Project: Research project
-
Endothelin and ACE2 Interactions, Implications for Diabetic Kidney Disease
Batlle, D. (PD/PI) & Wysocki, J. (Co-Investigator)
12/13/11 → 6/30/14
Project: Research project
-
Strategies for ACE2 Amplification to Treat Diabetic Kidney Disease
Batlle, D. (PD/PI)
National Institute of Diabetes and Digestive and Kidney Diseases
9/15/09 → 8/31/14
Project: Research project
-
Fellowship in Support of Molecular Regulation of Soluble RAGE and Implications for TID Complications
Batlle, D. (PD/PI)
12/1/08 → 2/28/10
Project: Research project
-
Nocturnal Hypertension in Type 1 Diabetes
Batlle, D. (PD/PI)
10/1/08 → 9/30/13
Project: Research project
-
Fellowship in Support of Melatonin in Type I Diabetics with Nocturnal Hypertension
Batlle, D. (PD/PI)
9/1/08 → 8/31/10
Project: Research project
-
Fellowship in Support of Melatonin in Type I Diabetics with Nocturnal Hypertension
Batlle, D. (PD/PI)
9/1/08 → 8/31/10
Project: Research project
-
Prot# 20070664: A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Fixed Dose Study of AMG 223 in Subjects with Chronic Kidney Disease on Hemodialysis with Hyperphosphatemia
Batlle, D. (PD/PI) & Schlueter, W. A. (Co-PD/PI)
Fresenius Medical Care North America, Amgen, Inc.
5/12/08 → 5/12/11
Project: Research project
-
ACE2 as Therapeutic Target for Kidney Disease in Diabetic Mice
Batlle, D. (PD/PI) & Wysocki, J. (Co-Investigator)
12/1/07 → 6/30/11
Project: Research project
-
Nocturnal Hypertension and Prevention of Microalbu
Batlle, D. (PD/PI)
King Pharmaceuticals Research and Development, Inc.
10/30/07 → 10/30/12
Project: Research project
-
Prot# 156-04-251: A Phase 3, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Arm Trial to Determine Long-Term Safety and Efficacy of Oral Tolvaptan Tablet Regimens in Adult Subjects with Autosomal Dominant Polycystic Kidney Disease
Batlle, D. (PD/PI), Tuazon, J. A. (PD/PI) & Ghossein, C. (Co-PD/PI)
Parexel, Otsuka Maryland Research Institute, Inc.
9/4/07 → 9/4/10
Project: Research project
-
The Effect of Telmisartan on ACE2 in Diabetic Kidney
Batlle, D. (PD/PI)
Boehringer Ingelheim International GmbH
1/1/07 → 1/1/09
Project: Research project
-
The Effect of Telmisartan on ACE2 in Diabetic Kidney
Batlle, D. (PD/PI)
Boehringer Ingelheim International GmbH
1/1/07 → 1/1/09
Project: Research project
-
Prot# 20050182: EVOLVE: Evaluation of Cinacalcet HCI Therapy to Lower CardioVascular Events
Batlle, D. (PD/PI), Tuazon, J. A. (PD/PI) & Schlueter, W. A. (Co-PD/PI)
Fresenius Medical Care North America, Amgen, Inc.
11/3/06 → 5/1/12
Project: Research project
-
Nocturnal Hypertension and Prevention of Microalbuminuria in Type I Diabetics
Batlle, D. (PD/PI), Molitch, M. E. (PD/PI), Molitch, M. E. (Co-PD/PI), Welty, L. J. (Co-PD/PI) & Molitch, M. E. (Co-Investigator)
National Institute of Diabetes and Digestive and Kidney Diseases
9/30/06 → 6/30/13
Project: Research project
-
Medical Education Grant: Center of Excellence in Chronic Kidney Disease (CKD) {Chicago Nephrology Day}
Batlle, D. (PD/PI)
10/19/05 → 10/18/08
Project: Research project